Skip to content

Expression and Mechanism of ROCK1/2 in Peripheral Blood of Sepsis Patients

Expression and Mechanism of ROCK1/2 in Peripheral Blood of Sepsis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126928
Enrollment
Unknown
Registered
2026-06-18
Start date
2026-06-18
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Healthy Control Group:None

Sponsors

Affiliated hangzhou first people's hospital, zhejiang university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for the sepsis patient group: 1. Diagnostic criteria: Must meet the diagnostic criteria for sepsis or septic shock as defined in the "International Consensus on the Third Edition of Definitions for Sepsis and Septic Shock". 2.Inclusion criteria for the sepsis patient group:2. Age range: 18 years old <=age <=75 years old. 3.Inclusion criteria for the sepsis patient group:3. Onset time: At the time of enrollment, it must be within 48 hours after the diagnosis of sepsis. 4.Inclusion criteria for the sepsis patient group:4. Informed consent: The patient himself or his legal authorized representative must voluntarily sign a written informed consent form. 5.Inclusion criteria for the healthy control group: 1. Health status: Through health questionnaires and routine physical examinations, there were no acute or chronic infectious diseases, autoimmune diseases, active malignant tumors, severe liver, kidney or blood system diseases, etc. 6.Inclusion criteria for the healthy control group:2. Age and gender matching: The age was matched with that of the case group (+/-5 years), and the gender ratio was similar. 7.Inclusion criteria for the healthy control group:3. Informed consent: The volunteers themselves voluntarily signed a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with major underlying diseases: Those with severe liver cirrhosis (Child-Pugh C grade), end-stage renal disease (relying on dialysis), NYHA cardiac function grade IV, diagnosed hematological malignancies, after solid organ or hematopoietic stem cell transplantation, and those requiring long-term use of immunosuppressive agents. 2. Individuals with special infection conditions: Those diagnosed with human immunodeficiency virus (HIV) infection or active tuberculosis. 3. Individuals with special physiological or pathological conditions: Pregnant or lactating women. 4. Sample collection limitations: There are cases where it is difficult to establish an intravenous access, or where severe coagulation disorders prevent the collection of sufficient and qualified blood samples. 5. Other circumstances that may interfere with the research results: Those who received blood products containing white blood cells within 24 hours before enrollment; any other situations that the researcher deems may affect the assessment of immune function or expose the subjects to unacceptable risks.

Design outcomes

Primary

MeasureTime frame
ROCK1/2;APACHE II Score;SOFA score;

Countries

China

Contacts

Public ContactHanbin Wang

Affiliated hangzhou first people's hospital, zhejiang university school of medicine

458154923@qq.com+86 15757119331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026